- Home
- Industry Reports
- Healthcare
- Medical Devices
- Asia Pacific Artificial Organs and Bionics Market – Size, Outlook, Trends and Forecast (2023 – 2030)
Bionics is the application of the biological methods and systems to overcome the disability of the body. Artificial organs are plotted devices which are integrated into the human by replacing the natural organ and are constructed by natural or synthetic polymer materials like metals and ceramics.
Asia Pacific Artificial Organ and Bionics Market Size and Growth:
Asia Pacific artificial organ and bionics market will grow with a CAGR of 15.2% during the forecast period 2019-2025. Increasing road accidents, lack of organ donors and increasing technological improvements in artificial organs and bionics are the factors contributing to the APAC market growth.
Asia Pacific Artificial Organ and Bionics Market Segments Share:
Asia Pacific artificial organs and bionics market is segmented by product into artificial organ and bionics. An artificial kidney, artificial heart and artificial liver are considered under the artificial organ. Vision bionics, orthopaedic bionics, cardiac bionics and brain bionics are considered under the bionics. By technology, the electronic bionics is an electronic device which is used in defence sector for exoskeleton suits to assist soldiers in carrying heavy loads in the battlefield and likely to have an emerging growth in artificial organ and bionics space.
By Geography, Asia-Pacific artificial organs and bionics market is projected to grow at the maximum CAGR which is significantly due to growing ageing population and huge consumer base, growing government initiatives for improving healthcare, and high disposable income. Japan and South Korea held significant market share in 2017 due to massive technological developments taking place in these regions.
Asia Pacific Artificial Organ and Bionics Market Segments trends:
- In July 2018, Medtronic PLC received FDA approval for less invasive heart pump implant plane procedure.
- In January 2018, Boston scientific received and FDA approved for spectra wave writer, spinal cord stimulator system.
Asia Pacific Artificial Organ and Bionics Market Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have a complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried out to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on year-on-year
Identifying DROC in the current market and their impact on altering market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The primary key players are:
- Baxter International Inc.
- Boston Scientific Corporation.
- Berlin Heart GmbH.
- Cochlear limited.
- Cyberonics Inc.
- Edward Lifesciences.
Along with these companies, there were many other companies considered in the report while analysing the Asia Pacific artificial organs and bionics market. These companies hold substantial share-owning to the nature of the industry whereas the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and stable customer base.
1. Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4. Market Dynamics
4.1. Drivers
4.1.1. Less number of organs donors.
4.1.2. Technological advancements.
4.1.3. Increasing of road accidents which lead to the amputations.
4.2 Restraints & Challenges
4.2.1. High cost
4.2.2. Inadequate experts to carry out the procedure
4.3 Opportunities
4.3.1 Demand for artificial organs and bionics in the health sector.
5. Asia Pacific Artificial Organs and Bionics Market – By Product
5.1. Artificial organs
5.2. Bionics
6. Asia Pacific Artificial Organs and Bionics Market – By Technology
6.1. Mechanical bionics
6.2. Electronic bionics
7. Asia Pacific Artificial Organs and Bionics Market – By Application
7.1 Healthcare
7.2 Defence
8. Asia Pacific Artificial Organs and Bionics Market – By Geography
8.1 Introduction
8.2 Asia Pacific
8.2.1. China
8.2.2. India
8.2.3. Japan
8.2.4. South Korea
8.2.5. Australia & New Zealand
8.2.6. Rest of APAC
9. Asia Pacific Artificial Organs and Bionics Market – Company Profiles
9.1. Abiomed Inc.
9.2. Asahi Kasei medical co. ltd
9.3. Baxter International Inc.
9.4. Boston Scientific Corporation.
9.5. Berlin Heart GmbH.
9.6. Cochlear limited.
9.7. Cyberonics Inc.
9.8. Edward Lifesciences.
9.9. Ekso Bionic
9.10. Roche Holding AG
9.11. Medtronic PLC
9.12. Gambro AB.
9.13. LifeNet Health Inc.
9.14. Otto bock healthcare GmbH.
9.15. F. Hoffman La Roche Ltd
10. Asia Pacific Artificial Organs and Bionics Market – Competitive Landscape
10.1. Market Share Analysis
10.2. Strategies Adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
11. Market Insights
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
12. Appendix
12.1 List of Tables
12.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Regional Report
$2,160.00 – $7,200.00
- EUR: €2,049.53 - €6,831.77
- INR: ₹179,619.81 - ₹598,732.71
- AED: د.إ7,927.20 - د.إ26,424.00
- GBP: £1,769.42 - £5,898.07
Description
Regional Reports
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Bionics is the application of the biological methods and systems to overcome the disability of the body. Artificial organs are plotted devices which are integrated into the human by replacing the natural organ and are constructed by natural or synthetic polymer materials like metals and ceramics.
Asia Pacific Artificial Organ and Bionics Market Size and Growth:
Asia Pacific artificial organ and bionics market will grow with a CAGR of 15.2% during the forecast period 2019-2025. Increasing road accidents, lack of organ donors and increasing technological improvements in artificial organs and bionics are the factors contributing to the APAC market growth.
Asia Pacific Artificial Organ and Bionics Market Segments Share:
Asia Pacific artificial organs and bionics market is segmented by product into artificial organ and bionics. An artificial kidney, artificial heart and artificial liver are considered under the artificial organ. Vision bionics, orthopaedic bionics, cardiac bionics and brain bionics are considered under the bionics. By technology, the electronic bionics is an electronic device which is used in defence sector for exoskeleton suits to assist soldiers in carrying heavy loads in the battlefield and likely to have an emerging growth in artificial organ and bionics space.
By Geography, Asia-Pacific artificial organs and bionics market is projected to grow at the maximum CAGR which is significantly due to growing ageing population and huge consumer base, growing government initiatives for improving healthcare, and high disposable income. Japan and South Korea held significant market share in 2017 due to massive technological developments taking place in these regions.
Asia Pacific Artificial Organ and Bionics Market Segments trends:
- In July 2018, Medtronic PLC received FDA approval for less invasive heart pump implant plane procedure.
- In January 2018, Boston scientific received and FDA approved for spectra wave writer, spinal cord stimulator system.
Asia Pacific Artificial Organ and Bionics Market Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have a complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried out to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on year-on-year
Identifying DROC in the current market and their impact on altering market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The primary key players are:
- Baxter International Inc.
- Boston Scientific Corporation.
- Berlin Heart GmbH.
- Cochlear limited.
- Cyberonics Inc.
- Edward Lifesciences.
Along with these companies, there were many other companies considered in the report while analysing the Asia Pacific artificial organs and bionics market. These companies hold substantial share-owning to the nature of the industry whereas the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and stable customer base.
1. Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4. Market Dynamics
4.1. Drivers
4.1.1. Less number of organs donors.
4.1.2. Technological advancements.
4.1.3. Increasing of road accidents which lead to the amputations.
4.2 Restraints & Challenges
4.2.1. High cost
4.2.2. Inadequate experts to carry out the procedure
4.3 Opportunities
4.3.1 Demand for artificial organs and bionics in the health sector.
5. Asia Pacific Artificial Organs and Bionics Market – By Product
5.1. Artificial organs
5.2. Bionics
6. Asia Pacific Artificial Organs and Bionics Market – By Technology
6.1. Mechanical bionics
6.2. Electronic bionics
7. Asia Pacific Artificial Organs and Bionics Market – By Application
7.1 Healthcare
7.2 Defence
8. Asia Pacific Artificial Organs and Bionics Market – By Geography
8.1 Introduction
8.2 Asia Pacific
8.2.1. China
8.2.2. India
8.2.3. Japan
8.2.4. South Korea
8.2.5. Australia & New Zealand
8.2.6. Rest of APAC
9. Asia Pacific Artificial Organs and Bionics Market – Company Profiles
9.1. Abiomed Inc.
9.2. Asahi Kasei medical co. ltd
9.3. Baxter International Inc.
9.4. Boston Scientific Corporation.
9.5. Berlin Heart GmbH.
9.6. Cochlear limited.
9.7. Cyberonics Inc.
9.8. Edward Lifesciences.
9.9. Ekso Bionic
9.10. Roche Holding AG
9.11. Medtronic PLC
9.12. Gambro AB.
9.13. LifeNet Health Inc.
9.14. Otto bock healthcare GmbH.
9.15. F. Hoffman La Roche Ltd
10. Asia Pacific Artificial Organs and Bionics Market – Competitive Landscape
10.1. Market Share Analysis
10.2. Strategies Adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
11. Market Insights
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
12. Appendix
12.1 List of Tables
12.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.